Outset Medical, Inc.
NASDAQ:OMMedical - Devices
Healthcare
$2.91 +18.16%
+$0.73 today
- Market cap
- $54.86M
- Beta
- 1.94
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$4.07
52W Low $3.00High $21.36
Volume 0.08M
Average 0.16M
Income Statement
Follow revenue through to earnings.
Revenue
$119.48M
FY 2025 · Annual
+5.1% YoYOperating Income
-$66.71M
FY 2025 · Annual
Net Income
-$81.65M
FY 2025 · Annual
Income Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 102.6M | 115.38M | 130.38M | 113.69M | 119.48M |
| Cost of Revenue | 94.99M | 97.54M | 101.38M | 75.13M | 72.72M |
| Gross Profit | 7.61M | 17.83M | 29M | 38.56M | 46.75M |
| Gross Margin | 7.4% | 15.5% | 22.2% | 33.9% | 39.1% |
| Research & Development | 36.74M | 48.86M | 57.31M | 38.4M | 21.24M |
| Selling, General & Admin | 101.39M | 130M | 141.46M | 113.54M | 92.23M |
| Operating Expenses | 138.13M | 178.85M | 198.77M | 151.94M | 113.46M |
| Depreciation & Amortization | 5.16M | 6.28M | 5.81M | 5.73M | 4.34M |
| EBITDA | (124.86M) | (152.81M) | (153.79M) | (97.89M) | (62.37M) |
| EBITDA Margin | -121.7% | -132.4% | -118.0% | -86.1% | -52.2% |
| Operating Income | (130.52M) | (161.02M) | (169.77M) | (113.38M) | (66.71M) |
| Operating Margin | -127.2% | -139.6% | -130.2% | -99.7% | -55.8% |
| Interest Income | 498K | 3.29M | 10.17M | 9.76M | 7.41M |
| Interest Expense | 1.72M | 3.57M | 12.68M | 23.87M | 13.95M |
| Other Income / Expenses | (1.22M) | (1.64M) | (2.5M) | (14.11M) | (14.22M) |
| Income Before Tax | (131.74M) | (162.66M) | (172.27M) | (127.49M) | (80.94M) |
| Pre-Tax Margin | -128.4% | -141.0% | -132.1% | -112.1% | -67.7% |
| Income Tax Expense | 199K | 295K | 523K | 491K | 718K |
| Net Income | (131.94M) | (162.96M) | (172.8M) | (127.98M) | (81.65M) |
| Net Margin | -128.6% | -141.2% | -132.5% | -112.6% | -68.3% |
| EPS (Basic) | (43.41) | (50.75) | (52.27) | (36.95) | (5.37) |
| EPS (Diluted) | (43.41) | (50.75) | (52.27) | (36.95) | (5.37) |
| 3.04M | 3.21M | 3.31M | 3.46M | 15.21M | |
| 3.04M | 3.21M | 3.31M | 3.46M | 15.21M |
OM Earnings Waterfall · TTM
NASDAQ:OM · Revenue to Net Income
Key Ratios
EPS$-4.16
Gross Margin40.7%
Net Margin-63.8%
P/E Ratio-2.5
P/S Ratio6.1
Analysis
$117.6M of revenue converted into -$74.8M of net income for the selected period. Gross margin is 40.7% and net margin is -63.8%, showing how much revenue survives after costs and taxes. EPS is $-4.16, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 |
How much revenue does OM generate?
Outset Medical, Inc. (OM) reported $119.48M of revenue in fiscal 2025.
Is OM profitable?
Outset Medical, Inc. (OM) reported -$81.65M of net income, with a net margin of -68.3%.
Continue the stock analysis
Jump to another research area for this company.